Showing results (1-10 of 601) with videos related to
Sort By:
Pageof 61
Acta Psychiatrica Belgica|September 1, 1987
Central dopaminergic mechanisms in schizophreniaF Owen, T J Crow, M PoulterPsychopharmacology|January 1, 1981
3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptorsA J Cross, T J Crow, F OwenBrain Research|May 7, 1984
Dopamine D2 receptors in substantia nigra in schizophreniaR Owen, F Owen, M Poulter, et al.Clinical Endocrinology|September 1, 1983
Hydroxy-indole-o-methyltransferase activity in human pineals: a comparison of controls and schizophrenicsF Owen, I N Ferrier, M Poulter, et al.Life Sciences|February 4, 1985
Reduced high affinity cholecystokinin binding in hippocampus and frontal cortex of schizophrenic patientsS M Farmery, F Owen, M Poulter, et al.Neuropharmacology|January 1, 1984
Characterisation and distribution of vasoactive intestinal polypeptide binding sites in human brainS M Farmery, F Owen, M Poulter, et al.Acta Psychiatrica Scandinavica. Supplementum|January 1, 1981
Neurotransmitter receptors in brain in schizophreniaF Owen, A J Cross, T J Crow, et al.Brain Research|November 14, 1983
[3H]R05-4864 and [3H]flunitrazepam binding in kainate-lesioned rat striatum and in temporal cortex of brains from patients with senile dementia of the Alzheimer typeF Owen, M Poulter, J L Waddington, et al.Psychopharmacology|January 1, 1982
Behavioural and biochemical effects of chronic amphetamine treatment in the vervet monkeyR M Ridley, H F Baker, F Owen, et al.The British Journal of Psychiatry : the Journal of Mental Science|July 1, 1981
Platelet monoamine oxidase activity in acute schizophrenia: relationship to symptomatology and neuroleptic medicationF Owen, R C Bourne, T J Crow, et al.Pageof 61